References
1. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. The oncologist.2013;18(4):381.
2. Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment. CA: a cancer journal for clinicians. 2018;68(2):153-165.
3. Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of cancer on survivors’ quality of life. Journal of oncology practice. 2014;10(5):332-338.
4. Huang I-C, Bhakta N, Brinkman TM, et al. Determinants and consequences of financial hardship among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. JNCI: Journal of the National Cancer Institute. 2019;111(2):189-200.
5. Kale HP, Carroll NV. Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivors. Cancer. 2016;122(8):283-289.
6. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. Journal of Clinical Oncology. 2016;34(15):1732.
7. Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer.Journal of Clinical Oncology. 2016;34(9):980.
8. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. Journal of oncology practice. 2015;11(2):145-150.
9. Guy Jr GP, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. Journal of Clinical Oncology. 2013;31(30):3749.
10. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. 2020;382(10):929-936.
11. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020.
12. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020.
13. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet. 2020;395(10228):931-934.
14. Hafiz H, Oei S-Y, Ring DM, Shnitser N. Regulating in Pandemic: Evaluating Economic and Financial Policy Responses to the Coronavirus Crisis. Boston College Law School Legal Studies Research Paper.2020(527).
15. Brenan M. U.S. Employees Increasingly Seeing COVID-19 Effects at Work. Gallup. 2020. https://news.gallup.com/poll/305237/employees-increasingly-seeing-covid-effects-work.aspx. . Accessed March 31, 2020.
16. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncology. 2020.
17. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology.2020;21(3):335-337.
18. Jacobson JJ, Epstein JB, Eichmiller FC, et al. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol.2012;4:15.
19. Position Statement: Otolaryngologists and the COVID-19 Pandemic.American Academy of Otolaryngology-Head and Neck Surgery 2020; https://www.entnet.org/content/otolaryngologists-and-covid-19-pandemic. Accessed April 1, 2020.
20. Chan JYK, Wong EWY, Lam W. Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong. JAMA Otolaryngology–Head & Neck Surgery. 2020.
21. Saibene AM, Allevi F, Biglioli F, Felisati G. Role and management of a head and neck department during the COVID-19 Outbreak in Lombardy.Otolaryngology—Head and Neck Surgery. 2020.
22. Information for Head and Neck Oncologists During the COVID-19 Pandemic (from the Survivorship, Supportive Care & Rehabilitation Service). 2020; https://www.ahns.info/wp-content/uploads/2020/03/synthesized-physician-doc.pdf. Accessed April 4, 2020.
23. Academy Supports CMS, Offers Specific Nasal Policy. 2020; https://www.entnet.org/content/academy-supports-cms-offers-specific-nasal-policy. Accessed April 4, 2020.
24. Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during the COVID-19 pandemic: Agility and collaboration toward a common goal.Journal of the National Comprehensive Cancer Network.2020;1(aop):1-4.
25. Jazieh A-R, Hadab AA, Olayan AA, et al. Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience. JCO Global Oncology. 2020(6):518-524.
26. Cornwall W. Can you put a price on COVID-19 options? Experts weigh lives versus economics. In. Science 2020.
27. Correia S, Luck S, Verner E. Pandemics Depress the Economy, Public Health Interventions Do Not: Evidence from the 1918 Flu. SSRN.2020;Pre-print.
28. Hone T, Mirelman AJ, Rasella D, et al. Effect of economic recession and impact of health and social protection expenditures on adult mortality: a longitudinal analysis of 5565 Brazilian municipalities.Lancet Glob Health. 2019;7(11):e1575-e1583.
29. Sullivan D, von Wachter T. Job Displacement and Mortality: An Analysis Using Administrative Data*. The Quarterly Journal of Economics. 2009;124(3):1265-1306.
30. Ruhm CJ. Recessions, healthy no more? Journal of Health Economics. 2015;42:17-28.
31. Cox J. Coronavirus job losses could total 47 million, unemployment rate may hit 32%, Fed estimates. CNBC. 2020. https://www.cnbc.com/2020/03/30/coronavirus-job-losses-could-total-47-million-unemployment-rate-of-32percent-fed-says.html. Accessed April 1, 2020.
32. Unemployment Insurance Weekly Claims Report April 2, 2020. In: Labor USDo, ed2020.
33. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay.Patient. 2017;10(3):295-309.
34. de Souza JA, Kung S, O’Connor J, Yap BJ. Determinants of Patient-Centered Financial Stress in Patients With Locally Advanced Head and Neck Cancer. J Oncol Pract. 2017;13(4):e310-e318.
35. Casselman B, Cohen P, Cowley S, et al. Coronavirus Cost to Businesses and Workers: ‘It Has All Gone to Hell’. The New York Times. March 15, 2020, 2020.
36. Mady LJ, Lyu L, Owoc MS, et al. Understanding financial toxicity in head and neck cancer survivors. Oral Oncol. 2019;95:187-193.
37. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016. Bethesda, MD: National Cancer Institute. In:2019.
38. Banegas MP, Guy Jr GP, de Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships.Health Affairs. 2016;35(1):54-61.
39. Mehnert A. Employment and work-related issues in cancer survivors.Critical reviews in oncology/hematology. 2011;77(2):109-130.
40. Steiner JF, Cavender TA, Main DS, Bradley CJ. Assessing the impact of cancer on work outcomes. Cancer. 2004;101(8):1703-1711.
41. Ekwueme DU, Yabroff KR, Guy Jr GP, et al. Medical costs and productivity losses of cancer survivors—United States, 2008–2011.MMWR Morbidity and mortality weekly report. 2014;63(23):505.
42. Health Insurance Coverage of the Total Population. 2018; https://www.kff.org/other/state-indicator/total-population/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed April 8, 2020.
43. Kirchhoff AC, Nipp R, Warner EL, et al. “Job lock” among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA oncology. 2018;4(5):707-711.
44. Blinder VS, Gany FM. Impact of Cancer on Employment. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2020;38(4):302.
45. Garfield R, Orgera K, Damico A. The Coverage Gap: Uninsured Poor Adults in States that Do Not Expand Medicaid. January 2020. Accessed April 8, 2020.
46. Cost-Sharing for Plans Offered in the Federal Msrketplace, 2014-2020. December 9, 2019; https://www.kff.org/slideshow/cost-sharing-for-plans-offered-in-the-federal-marketplace-2014-2020/. Accessed April 8, 2020.
47. Fehr R, Kamal R, Cox C. How ACA Marketplace Premiums Are Changing by County in 2020. November 7, 2019; https://www.kff.org/health-costs/issue-brief/how-aca-marketplace-premiums-are-changing-by-county-in-2020/. Accessed April 8, 2020.
48. Pollitz K. What People (and Policymakers) Can Do About Losing Coverage During the COVID-19 Crisis. March 27, 2020; https://www.kff.org/coronavirus-policy-watch/what-people-and-policymakers-can-do-about-losing-coverage-during-the-covid-19-crisis/. Accessed April 8, 2020.
49. Senior K. Battling cancer and the recession. Lancet Oncol.2009;10(3):212-213.
50. Woolhandler S, Himmelstein DU. Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance. Annals of Internal Medicine. 2020.
51. Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral cancer medication discontinuation in the elderly. Journal of Managed Care Pharmacy. 2014;20(7):669-675.
52. de Souza JA, Kung S, O’Connor J, Yap BJ. Determinants of patient-centered financial stress in patients with locally advanced head and neck cancer. Journal of oncology practice.2017;13(4):e310-e318.
53. Costas-Muniz R, Leng J, Aragones A, et al. Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients. Ethnicity & health. 2016;21(2):118-128.
54. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions.Journal of oncology practice. 2011;7(3S):46s-51s.
55. Ennis KY, Chen M-H, Smith GC, et al. The Impact of Economic Recession on the Incidence and Treatment of Cancer. J Cancer.2015;6(8):727-733.
56. Zheng Z, Jemal A, Tucker-Seeley R, et al. Worry About Daily Financial Needs and Food Insecurity Among Cancer Survivors in the United States. 2020;18(3):315.
57. Maruthappu M, Watkins J, Noor AM, et al. Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis.Lancet. 2016;388(10045):684-695.
58. Jahoda M. Economic recession and mental health: Some conceptual issues. Journal of social Issues. 1988;44(4):13-23.
59. Lewis G, Sloggett A. Suicide, deprivation, and unemployment: record linkage study. BMJ. 1998;317(7168):1283-1286.
60. Reeves A, McKee M, Stuckler D. Economic suicides in the Great Recession in Europe and North America. British Journal of Psychiatry. 2014;205(3):246-247.
61. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2008;26(29):4731-4738.
62. Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Suicide among cancer patients. Nat Commun. 2019;10(1):207.
63. Osazuwa-Peters N, Simpson MC, Zhao L, et al. Suicide risk among cancer survivors: Head and neck versus other cancers. Cancer.2018;124(20):4072-4079.
64. Katz MS. Cancer Care in the Time of COVID-19. 2020; https://connection.asco.org/blogs/cancer-care-time-covid-19?cid=DM4800&bid=40974521. Accessed March 31, 2020.
65. Yabroff KR, Bradley C, Shih Y-CT. Understanding financial hardship among cancer survivors in the United States: Strategies for prevention and mitigation. Journal of Clinical Oncology. 2019:JCO. 19.01564.
66. Powell VD, Silveira MJ. What Should Palliative Care’s Response be to the COVID-19 Epidemic? Journal of Pain and Symptom Management.
67. Fausto J, Hirano L, Lam D, et al. Creating a Palliative Care Inpatient Response Plan for COVID19 - The UW Medicine Experience.J Pain Symptom Manage. 2020.
68. Calton B, Abedini N, Fratkin M. Telemedicine in the Time of Coronavirus. J Pain Symptom Manage. 2020.